STACEY KRASNOFF: Open Payments
NPI 1700436136 · WEST HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,212 in 86 payments from 27 companies in 2025. Trend: 2023 $685 · 2024 $786 · 2025 $2,212
Food & beverage: $2,212
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $280 |
| Indivior Inc. | 9 | $269 |
| Novo Nordisk Inc | 9 | $219 |
| Otsuka America Pharmaceutical, Inc. | 6 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $148 |
| Lilly USA, LLC | 6 | $146 |
| GlaxoSmithKline, LLC. | 7 | $145 |
| Lundbeck LLC | 6 | $141 |
| ABBVIE INC. | 4 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
Products named: SUBLOCADE, REXULTI, TRELEGY ELLIPTA, Wegovy, BREZTRI, FARXIGA, TRINTELLIX, VRAYLAR.
Industry payments across CT — which companies pay providers there.
